CRVO is CervoMed Inc. (Healthcare) — a non-dividend-paying stock. Trading at $2.56. Market cap: $38M. Capital Quality Rank: 3/100 — Systemic risk.
Stock snapshot
| Price | $2.56 |
| Market cap | $38M |
| Sector | Healthcare |
| Exchange | NCM |
| Pays dividend | No |
Capital Quality & fundamentals
DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.
| Capital Quality Rank (1-100) | 3 / 100 · Systemic risk |
| ROIC (TTM) | -223.8% |
| Shareholder buyback yield | -10.71% |
| Altman Z-score zone | Distress |
About CRVO
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod, has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
Related non-dividend companies
Other non-dividend stocks investors research alongside CRVO. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is CRVO's current stock price?
CRVO (CervoMed Inc.) is currently trading at $2.56.
Does CRVO pay a dividend?
CRVO (CervoMed Inc.) does not currently pay a regular dividend.
What is CRVO's Capital Quality Rank?
CRVO has a Capital Quality Rank of 3/100 — Systemic risk. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.
Track CRVO in DiviDrip
Add CRVO to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search CRVO and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-04. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.